细菌感染的肠外初始治疗方案：多重耐药革兰氏阴性杆菌感染——产超广谱β-内酰胺酶菌、产碳青霉烯酶肠杆菌科细菌、耐碳青霉烯鲍曼不动杆菌。

Calculated parenteral initial treatment of bacterial infections: Infections with multi-resistant Gram-negative rods - ESBL producers, carbapenemase-producing Enterobacteriaceae, carbapenem-resistant Acinetobacter baumannii.

作者信息

Grabein Béatrice, Ebenhoch Michael, Kühnen Ernst, Thalhammer Florian

机构信息

Stabsstelle Klinische Mikrobiologie und Krankenhaushygiene, Klinikum der Universität München, Munich, Germany.

Stabsstelle Hygiene, Klinische Infektiologie und Mikrobiologie, BG-Unfallklinik Murnau, Germany.

出版信息

GMS Infect Dis. 2020 Mar 26;8:Doc04. doi: 10.3205/id000048. eCollection 2020.

This is the sixteenth chapter of the guideline "Calculated initial parenteral treatment of bacterial infections in adults - update 2018" in the 2 updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been translated to address an international audience. Infections due to multiresistant Gram-negative rods are challenging. In this chapter recommendations for targeted therapy for infections caused by ESBL-producing Enterobacteriaceae, carbapenemase-producing Enterobacteriaceae and carbapenem-resistant are given, based on the limited available evidence.